Roche (OTCMKTS:RHHVF) Stock Price Up 4.4% – What’s Next?
by Teresa Graham · The Cerbat GemRoche Holding AG (OTCMKTS:RHHVF – Get Free Report)’s share price shot up 4.4% on Thursday . The stock traded as high as $445.8640 and last traded at $441.7080. Approximately 180 shares traded hands during trading, a decline of 99% from the average daily volume of 12,650 shares. The stock had previously closed at $423.1575.
Roche Stock Up 4.4%
The company’s 50 day moving average is $438.99 and its 200-day moving average is $419.06.
Roche Company Profile
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.